| Clinical Study "Common" Name (formal title) | Number of enrollees (per protocol [PP]/intent-to-treat [ITT]) | Funding source (pharmaceutical company/National Institutes of Health [NIH]) | Year complete | Primary publication | Full study treatment protocol/patient disposition |
|---|---|---|---|---|---|
| Incidence, Predictors and Re-treatment Outcomes of Recurrent Myopic Choroidal Neo-vascularization | 167 | RAJA NARAYANAN DBT Wellcome Trust India Alliance Clinical Research Centre Grant IA/CRC/19/1/610010 | 2022 | Jain M, et al. PLOS One. 2022;17:e0271342. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0271342 |